Bayer is set to acquire the precision therapeutics developer backed by Alexandria Venture Investments, Celgene and SoftBank, with another $500m in milestone payments up for grabs.

Pulse Medical and BioMap are among the companies that raised nine-figure rounds, while Amwell bought two corporate-backed companies at once.

The all-stock transaction is expected to close by the end of this year and will provide an exit to Qualcomm Ventures.

The multi-corporate-backed biologic pill developer has listed on the Nasdaq Global Market, pricing the shares below their range.

Pulse Medical and BioMap are among the companies that raised nine-figure rounds, while Amwell bought two corporate-backed companies at once.

The offering would produce $500m, including up to $70.6m from the sale of new shares, and offer exits to Max Group and TVS.

The corporate-backed consumer credit platform operator will get a Nasdaq listing from the transaction, which will include $120m in Pipe financing co-led by Palantir Technologies.

Info Edge, Intel, SoftBank and Tencent are all in line for exits as PolicyBazaar files for an initial public offering in India.

Mitsui and Nan Fung are among the backers celebrating Rallybio’s flotation on the Nasdaq Global Select Market following an $80.6m offering.

The GV-backed cardiovascular therapeutics company has priced an upsized offering on Nasdaq, with the shares closing just marginally higher on the first day.